1. Manufofi na asali da ka'idojin fasaha na endoscopes masu yawa
Endoscope mai yawan amfani da na'urar likita ce da za a iya sake amfani da ita wadda ke shiga jikin ɗan adam ta cikin ramin jikin ɗan adam ko kuma ƙaramin yankewa a cikin tiyata mai ƙarancin shiga don taimakawa likitoci su gano cututtuka ko taimakawa wajen tiyata. Tsarin endoscope na likitanci ya ƙunshi sassa uku na asali: jikin endoscope, tsarin sarrafa hoto da kuma tsarin tushen haske. Jikin endoscope kuma ya ƙunshi manyan abubuwa kamar ruwan tabarau na daukar hoto, na'urori masu auna hoto (CCD ko CMOS), da'irori na samu da sarrafawa. Daga hangen nesa na zamani na fasaha, endoscopes masu yawan amfani sun samo asali daga endoscopes masu tauri zuwa fiber endoscopes zuwa lantarki. Ana yin fiber endoscopes ta amfani da ƙa'idar isar da fiber na gani. Sun ƙunshi dubban zare na fiber na gilashi da aka tsara don samar da hasken haske, kuma ana watsa hoton ba tare da murɗewa ba ta hanyar maimaita refraction. Endoscopes na lantarki na zamani suna amfani da na'urori masu auna micro-image da fasahar sarrafa siginar dijital don inganta ingancin hoto da daidaiton ganewar asali sosai.
2. Yanayin kasuwa na na'urorin endoscopes da za a iya sake amfani da su
| Girman Rukuni | Type | MakwatinSzomo | Bayani |
|
Tsarin Samfuri" | Endoscopy mai ƙarfi | 1. Girman kasuwar duniya ya kai dala biliyan 7.2 na Amurka.2. Endoscope mai ƙarfi na haske shine ɓangaren da ke bunƙasa cikin sauri, wanda a hankali yake maye gurbin endoscope na haske na fari na gargajiya. | 1. Wuraren da ake amfani da su: tiyatar gabaɗaya, ilimin fitsari, tiyatar ƙirji da kuma ilimin mata.2. Manyan masana'antun: Karl Storz, Mindray, Olympus, da sauransu. |
| Endoscopy Mai Sauƙi | 1. Girman kasuwar duniya shine yuan biliyan 33.08. 2. Olympus yana da kashi 60% (filin endoscope mai sassauƙa). | 1. Endoscopes na hanji suna wakiltar sama da kashi 70% na kasuwar endoscope mai sassauƙa 2. Manyan masana'antun: Olympus, Fuji, sonoscape, Aohua, da sauransu. | |
|
Ka'idar Hoto | Endoscope na gani | 1. Girman kasuwar duniya na na'urorin endoscopes masu hasken sanyi shine yuan biliyan 8.67. Kasuwar Lympus ta 2.0 ta wuce kashi 25%.. | 1. Dangane da ƙa'idar hoton gani na geometric 2. Ya ƙunshi tsarin ruwan tabarau na zahiri, tsarin watsawa/relay na gani, da sauransu. |
|
| Endoscope na lantarki | Tallace-tallacen na'urorin lantarki masu inganci a duniya sun kai dala miliyan 810. | 1. Dangane da hanyoyin canza bayanai na photoelectric da sarrafa hotuna 2. Ya haɗa da tsarin ruwan tabarau na zahiri, firikwensin photoelectric na hoto, da sauransu. |
|
Aikace-aikacen Asibiti | Endoscopy na narkewar abinci | Yana mamaye kashi 80% na kasuwar ruwan tabarau mai laushi, wanda Olympus ke da kashi 46.16%. | Alamar gidasonoscape Ma'aikatan lafiya sun zarce Fuji a kasuwar asibitocin sakandare. |
| Endoscopy na numfashi | Olympus ya kai kashi 49.56% na jimillar kaso na kasuwar na'urorin endoscopes na narkewar abinci. | Sauyawar gida na ƙara sauri, kuma Aohua Endoscopy ya ƙaru sosai. | |
| Laparoscopy/Ciwon Gaɓɓai | Thoracoscopy da laparoscopy sune ke da alhakin kashi 28.31% na kasuwar endoscope ta China. | 1. Rabon fasahar 4K3D ya karu da kashi 7.43%. 2. Mindray Medical ta zo ta farko a asibitocin sakandare. |
1)Kasuwar duniya: Olympus ya mamaye kasuwar ruwan tabarau masu laushi (60%), yayin da kasuwar ruwan tabarau masu tauri ke ƙaruwa akai-akai (dala biliyan 7.2 na Amurka). Fasaha mai haske da 4K3D sun zama alkiblar kirkire-kirkire.
2)Kasuwar China: Bambancin yankuna: Guangdong ce ke da mafi yawan adadin sayayya, lardunan bakin teku suna da rinjayen samfuran da aka shigo da su daga ƙasashen waje, kuma maye gurbin kayayyaki na cikin gida yana ƙaruwa a yankunan tsakiya da yamma.Nasarar gida:Yawan ruwan tabarau masu tauri da ake samu a wurare daban-daban shine kashi 51%, kuma ƙofofin ruwan tabarau masu laushi/Ostiraliya da China sun kai kashi 21% jimilla. Manufofi suna haɓaka maye gurbin ruwan tabarau masu inganci.Rarraba Asibiti: Asibitocin manyan makarantu sun fi son kayan aiki da aka shigo da su daga ƙasashen waje (kashi 65% na kaso), kuma asibitoci na sakandare sun zama wani babban ci gaba ga kamfanonin cikin gida.
3. Fa'idodi da ƙalubalen na'urorin endoscopes da za a iya sake amfani da su
| Fa'idodi | Bayyanar Musamman | Tallafin bayanai |
| Fitaccen aikin tattalin arziki | Ana iya sake amfani da na'ura ɗaya sau 50-100, tare da farashin dogon lokaci ƙasa da na'urorin endoscopes da za a iya zubarwa (kuɗin amfani ɗaya 1/10 ne kawai). | Misali, a ɗauki gastroenteroscopy: farashin siyan na'urar endoscope mai sake amfani shine RMB 150,000-300,000 (ana iya amfani da ita tsawon shekaru 3-5), kuma farashin na'urar endoscope mai yuwuwa shine RMB 2,000-5,000. |
| Babban balaga ta fasaha | Ana fifita fasahohi kamar su hoton 4K da kuma ganewar asali ta hanyar amfani da fasahar AI don yin amfani da na'urori masu yawa, tare da haske da haske fiye da na amfani da lokaci ɗaya da kashi 30%-50%. | A shekarar 2024, saurin shigar 4K a cikin na'urorin endoscopes masu girman gaske na duniya zai kai kashi 45%, kuma ƙimar ayyukan da aka taimaka wa AI za ta wuce kashi 25%. |
| Mai ƙarfi daidaitawa ta asibiti | An yi jikin madubin da kayan aiki masu ɗorewa (ƙarfe + polymer na likitanci) kuma ana iya daidaita shi da girman marasa lafiya daban-daban (kamar madubai masu siriri ga yara da madubai na yau da kullun ga manya). | Yawan dacewa da na'urorin endoscope masu tauri a tiyatar kashin baya shine kashi 90%, kuma nasarar da na'urorin endoscope masu sassauƙa ke samu a fannin gastroenterology ya wuce kashi 95%. |
| Manufofi da daidaiton sarkar samar da kayayyaki | Kayayyakin da za a iya sake amfani da su su ne suka fi shahara a duniya, kuma tsarin samar da kayayyaki ya tsufa (Olympus,sonoscape da sauran kamfanoni suna da tsarin ajiyar kaya na ƙasa da wata 1). | Kayan aiki masu sake amfani da su sun kai sama da kashi 90% na sayayya a asibitocin manyan makarantu na kasar Sin, kuma manufofi ba su takaita amfani da kayan aiki masu sake amfani da su ba.. |
| Kalubale | Takamaiman Matsaloli | Tallafin bayanai |
| Haɗarin tsaftacewa da tsaftacewa | Sake amfani da shi yana buƙatar tsauraran hanyoyin kashe ƙwayoyin cuta (dole ne ya bi ƙa'idodin AAMI ST91), kuma rashin yin aiki yadda ya kamata na iya haifar da kamuwa da cuta a tsakanin mutane (ƙimar kamuwa da cuta 0.03%). | A shekarar 2024, Hukumar Kula da Lafiya ta Amurka (FDA) ta dawo da na'urorin endoscope guda 3 da za a iya sake amfani da su saboda gurɓatar ƙwayoyin cuta da ke faruwa sakamakon tsaftace ragowar sinadarai. |
| Babban kuɗin kulawa | Ana buƙatar gyaran ƙwararru (kayan tsaftacewa + aiki) bayan kowane amfani, kuma matsakaicin kuɗin gyaran shekara-shekara ya kai kashi 15%-20% na farashin siyan.. | Matsakaicin kuɗin kulawa na endoscope mai sassauƙa a kowace shekara shine yuan 20,000-50,000, wanda ya fi na endoscope mai yuwuwa 100% girma (babu kulawa). |
| Matsin lamba na maimaita fasaha | Fasahar endoscope mai amfani da za a iya zubarwa ta kama (misali, farashin module na 4K ya ragu da kashi 40%), sake amfani da extrusion a kasuwa mai ƙarancin riba. | A shekarar 2024, karuwar kasuwar endoscope ta kasar Sin da za a iya zubarwa za ta kai kashi 60%, kuma wasu asibitoci na gida za su fara sayen endoscopes da za a iya zubarwa don maye gurbin endoscopes masu ƙarancin amfani da za a iya sake amfani da su. |
| Ƙa'idoji masu tsauri | Hukumar Kula da Lafiya ta Tarayyar Turai (MDR) da Hukumar Kula da Lafiya ta Amurka (FDA) sun ɗaga ƙa'idodin sake sarrafawa don na'urorin endoscopes masu sake amfani, wanda hakan ya ƙara farashin bin ƙa'idodi ga kamfanoni (kuɗin gwaji ya ƙaru da kashi 20%). | A shekarar 2024, yawan dawo da na'urorin endoscopes da za a iya sake amfani da su daga China saboda matsalolin bin ka'ida zai kai kashi 3.5% (kashi 1.2% kacal a shekarar 2023). |
4. Matsayin Kasuwa da Manyan Masana'antun
Kasuwar endoscope ta duniya ta yanzu tana gabatar da halaye masu zuwa:
Tsarin kasuwa:
Kamfanonin ƙasashen waje sun mamaye kasuwa: Manyan kamfanonin ƙasashen duniya kamar KARL STORZ da Olympus har yanzu suna da babban hannun jari a kasuwa. Idan aka ɗauki hysteroscopes a matsayin misali, manyan kamfanoni uku na tallace-tallace a shekarar 2024 duk kamfanonin ƙasashen waje ne, wanda ya kai jimillar kashi 53.05%.
Karuwar samfuran cikin gida: A cewar bayanan fasahar dijital ta Zhongcheng, kaso na kasuwa na endoscopes na cikin gida ya karu daga ƙasa da kashi 10% a shekarar 2019 zuwa kashi 26% a shekarar 2022, tare da matsakaicin ci gaban shekara-shekara sama da kashi 60%. Kamfanonin da suka wakilci sun haɗa da Mindray,sonoscape, Aohua, da sauransu.
Mayar da hankali kan gasar fasaha:
Fasahar daukar hoto: ƙudurin 4K, firikwensin CMOS wanda ke maye gurbin CCD, fasahar fadada filin EDOF mai zurfi, da sauransu.
Tsarin na'urar zamani: Tsarin na'urar bincike mai maye gurbinsa yana tsawaita tsawon rayuwar kayan aikin da ke cikin babban ɓangaren.
Tsaftacewa Mai Hankali: Sabon tsarin tsaftacewa wanda ya haɗu da gane gani na AI tare da daidaita daidaiton sinadaran tsaftacewa masu yawa na enzyme.
| Matsayi
| Alamar kasuwanci | Kasuwar China | Manyan Yankunan Kasuwanci | Fa'idodin fasaha da aikin kasuwa |
| 1 | Olympus | Kashi 46.16% | Na'urorin endoscope masu sassauƙa (70% a cikin ilimin gastroenterology), endoscopy, da tsarin ganewar asali wanda ke taimakawa ta hanyar AI. | Fasahar daukar hoto ta 4K tana da kaso mafi girma a kasuwar duniya na sama da kashi 60%, asibitocin manyan makarantu na kasar Sin suna da kashi 46.16% na sayayya, kuma masana'antar Suzhou ta cimma nasarar samar da kayayyaki a yankunan karkara.. |
| 2 | Fujifilm | 19.03% | Endoscope mai sassauƙa (fasahar daukar hoton laser mai shuɗi), endoscope mai siririn numfashi (4-5mm). | Kasuwar ruwan tabarau mai laushi ta biyu mafi girma a duniya, wacce ita ce kasuwar asibiti ta biyu a China, ta zarce kasuwar sonoscape Medical, kuma kudaden shiga a shekarar 2024 za su ragu da kashi 3.2% duk shekara.. |
| 3 | Karl Storz | 12.5% | Endoscope mai ƙarfi (laparoscopy ya kai kashi 45%), fasahar haske ta 3D, exoscope. | Kasuwar endoscope mai tsauri ta kasance ta farko a duniya. An amince da kayayyakin da ake samarwa a cikin gida daga masana'antar Shanghai. Sabbin sayayya na laparoscopes masu haske na 3D sun kai kashi 45%. |
| 4 | Sonoscape likita | 14.94% | Endoscope mai sassauƙa (endoscope na duban dan tayi), tsarin gano polyp na AI, tsarin endoscope mai ƙarfi. | Kamfanin yana matsayi na huɗu a kasuwar ruwan tabarau mai laushi a China, inda asibitoci na manyan makarantu ke da kashi 30% na siyan kayayyakin 4K+AI, kuma kudaden shiga sun karu da kashi 23.7% a shekara ta 2024. |
| 5 | HOYA(Pentax Medical） | 5.17% | Endoscope mai sassauƙa (gastroenteroscopy), endoscope mai tauri (otolaryngology). | Bayan da HOYA ta same shi, tasirin haɗin gwiwa ya yi ƙasa, kuma kason kasuwarsa a China ya faɗi daga cikin goma na farko. Kuɗin shigarsa a shekarar 2024 ya faɗi da kashi 11% duk shekara. |
| 6 | Endoscopy na Aohua | 4.12% | endoscopy mai sassauci (gastroenterology), endoscopy mai ƙarfi. | Kasuwar gaba ɗaya a rabin farko na 2024 ita ce kashi 4.12% (mai laushi endoscope + hard endoscope), kuma ribar da aka samu daga endoscopes masu inganci za ta ƙaru da kashi 361%. |
| 7 | Mindray Medical | 7.0% | Endoscope mai ƙarfi (hysteroscope ya kai kashi 12.57%), mafita ga asibitoci na asali. | Kasar Sin tana matsayi na uku a kasuwar na'urar daukar hoton endoscope mai tsauri, tare da asibitocin gundumomi'karuwar sayayya da ta wuce kashi 30%, kuma rabon kudaden shiga na kasashen waje ya karu zuwa kashi 38% a shekarar 2024. |
| 8 | likitan ido | 4.0% | Fluoroscope (Urology, Gynecology), ma'aunin madadin gida. | Kasuwar China ta amfani da ruwan tabarau mai ƙarfi mai haske ya wuce kashi 40%, fitar da kayayyaki zuwa Kudu maso Gabashin Asiya ya karu da kashi 35%, kuma jarin bincike da ci gaba ya kai kashi 22%. |
| 9 | Stryker | 3.0% | Tsarin kewayawa mai ƙarfi na jijiyoyin jijiyoyi, tsarin kewayawa mai haske na urology, arthroscope. | Kasuwar na'urorin neuroendoscopes ta zarce kashi 30%, kuma karuwar sayen asibitocin gundumomi a China ta kai kashi 18%. Mindray Medical ta rage kasuwar asali. |
| 10 | Sauran Alamu | 2.37% | Alamun yanki (kamar Rudolf, Toshiba Medical), takamaiman sassa (kamar madubin ENT). |
5. Ci gaban fasaha na asali
1)Hoton Narrow-band (NBI): Hoton Narrow-band wata hanya ce ta zamani ta gani wadda ke inganta yadda ake ganin tsarin saman mucosal da kuma tsarin microvascular ta hanyar amfani da takamaiman raƙuman shuɗi-kore. Nazarin asibiti ya nuna cewa NBI ta ƙara daidaiton ganewar raunukan ciki da kashi 11 cikin ɗari (94% vs 83%). A cikin ganewar cutar metaplasia ta hanji, ƙarfin ji ya ƙaru daga 53% zuwa 87% (P<0.001). Ya zama muhimmin kayan aiki don tantance cutar kansar ciki da wuri, wanda zai iya taimakawa wajen bambance raunuka marasa lahani da marasa lahani, biopsy da aka yi niyya, da kuma fayyace iyakokin yankewa.
2)Zurfin fasahar filin EDOF mai zurfi: Fasahar EDOF da Olympus ta ƙirƙira ta cimma zurfin filin ta hanyar raba hasken haske: ana amfani da prism guda biyu don raba hasken zuwa haske biyu, suna mai da hankali kan hotuna na kusa da na nesa bi da bi, sannan a ƙarshe su haɗa su cikin hoto mai haske da laushi tare da zurfin filin akan firikwensin. A cikin lura da mucosa na ciki, ana iya gabatar da dukkan yankin rauni a sarari, wanda hakan ke inganta yawan gano raunuka sosai.
3)Tsarin daukar hoto mai yawa
EVIS X1™tsarin ya haɗa da hanyoyin daukar hoto masu ci gaba da yawa: Fasahar TXI: inganta ƙimar gano adenoma (ADR) da kashi 13.6%; Fasahar RDI: yana haɓaka ganin jijiyoyin jini masu zurfi da wuraren zubar jini; Fasahar NBI: yana inganta lura da tsarin mucosal da jijiyoyin jini; yana canza endoscopy daga "kayan aikin lura" zuwa "dandalin ganewar asali na taimako".
6. Yanayin manufofi da kuma yanayin masana'antu
Manyan manufofin da za su shafi masana'antar endoscopy a 2024-2025 sun haɗa da:
Manufar sabunta kayan aiki: "Shirin Aiki don Inganta Sabbin Kayan Aiki da Sauya Kayan Amfani" na Maris 2024 yana ƙarfafa cibiyoyin kiwon lafiya su hanzarta sabuntawa da sauya kayan aikin daukar hoto na likitanci.
Sauya kayan cikin gida: Tsarin 2021 yana buƙatar siyan samfuran cikin gida 100% don laparoscopes na 3D, choledochoscopes, da kuma foramina na intervertebral.
Inganta amincewa: Ana daidaita na'urorin endoscope na likitanci daga na'urorin likitanci na Aji na III zuwa na Aji na II, kuma lokacin yin rijistar yana raguwa daga fiye da shekaru 3 zuwa shekaru 1-2.
Waɗannan manufofi sun inganta kirkire-kirkire da dabarun bincike da kuma samun damar kasuwa ga na'urorin endoscope na cikin gida, wanda hakan ya samar da yanayi mai kyau na ci gaba ga masana'antar.
7. Yanayin ci gaba na gaba da ra'ayoyin ƙwararru
1)Haɗakar fasaha da kirkire-kirkire
"Fasahar haɗin gwiwa mai siffar biyu": Laparoscope (mai tauri) da endoscope (mai laushi) suna aiki tare a tiyata don magance matsalolin asibiti masu rikitarwa.
"Taimakon fasahar wucin gadi": Algorithms na AI suna taimakawa wajen gano raunuka da kuma yanke shawara kan ganewar asali.
Nasarar kimiyyar kayan aiki": Haɓaka sabbin kayan aikin bincike waɗanda suka fi ɗorewa kuma masu sauƙin tsaftacewa.
2)Bambancin kasuwa da ci gaba
Masana sun yi imanin cewa endoscopes da za a iya amfani da su da kuma endoscopes da za a iya sake amfani da su za su daɗe suna rayuwa:
Kayayyakin da za a iya zubarwa: sun dace da yanayi masu saurin kamuwa da cututtuka (kamar gaggawa, kula da yara) da kuma cibiyoyin kiwon lafiya na farko.
Kayayyakin da za a iya sake amfani da su: kiyaye fa'idodin farashi da fasaha a cikin yanayi mai yawan amfani a manyan asibitoci.
Nazarin Lafiya na Mole ya nuna cewa ga cibiyoyin da ke amfani da matsakaicin na'urori sama da 50 a kowace rana, cikakken farashin kayan aikin da za a iya sake amfani da su ya yi ƙasa.
3)Sauya gurbin gida yana hanzarta
Kason da ake samu a cikin gida ya karu daga kashi 10% a shekarar 2020 zuwa kashi 26% a shekarar 2022, kuma ana sa ran zai ci gaba da karuwa. A fannin gwajin hasken rana da kuma na'urar duban dan tayi ta confocal, fasahar kasarmu ta riga ta ci gaba a duniya. Bisa ga manufofi, "lokaci ne kawai" a kammala maye gurbin maganin a cikin gida.
4)Daidaito tsakanin fa'idodin muhalli da tattalin arziki
Na'urorin endoscopes da za a iya sake amfani da su a ka'ida na iya rage yawan amfani da albarkatu da kashi 83%, amma matsalar maganin sharar ruwa a cikin tsarin tsaftace muhalli na buƙatar a magance ta. Bincike da haɓaka kayan da za su iya lalacewa ta hanyar halitta muhimmin alkibla ne a nan gaba.
Tebur: Kwatanta tsakanin endoscopes masu sake amfani da su da waɗanda za a iya zubarwa
| Girman Kwatantawa | Ana iya sake amfani da shi Ƙanshin ciki | Za a iya zubarwa Ƙanshin ciki |
| Kudin kowane amfani | Ƙasa (Bayan rabawa) | Babban |
| Zuba jari na farko | Babban | Ƙasa |
| Ingancin hoto | mai kyau kwarai
| mai kyau |
| Hadarin kamuwa da cuta | Matsakaici (ya danganta da ingancin tsaftacewa) | Ƙasa sosai |
| Amincin muhalli | Matsakaici (yana samar da ruwan sharar gida mai kashe ƙwayoyin cuta) | Talauci (Sharar filastik) |
| Yanayi masu dacewa | Yawan amfani da shi a manyan asibitoci | Asibitoci na farko/sassan da ke da saurin kamuwa da cuta |
Kammalawa: A nan gaba, fasahar endoscopic za ta nuna yanayin ci gaba na "daidaitacce, mai ƙarancin mamayewa, da kuma wayo", kuma endoscopes masu sake amfani da su za su kasance manyan abubuwan da ke haifar da wannan tsari na juyin halitta.
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China wanda ya ƙware a fannin amfani da endoscopic, kamar suƙarfin biops, hemoclip, tarkon polyp,allurar sclerotherapy, feshi catheter,gogewar cytology, waya mai jagora, Kwandon ɗaukar dutse, catheter na magudanar ruwa ta hanci,rufin shiga ureteralkumarufin shiga ureteral tare da tsotsada sauransu. wanda ake amfani da shi sosai a cikin EMR, ESD, ERCP. Kayayyakinmu an ba su takardar shaidar CE, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma suna ba wa abokin ciniki yabo da yabo sosai!
Lokacin Saƙo: Yuli-25-2025